Table: Kissei Pharm -2018/19 group results

Kissei Pharmaceutical

08/05/2019 07:00

May 8 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           72.30           74.01          61.40        31.20    
               (-2.3 pct)      (+3.2 pct)     (-15.1 pct)  (-12.5 pct) 
  Operating        6.20            9.89           1.00         1.80    
               (-37.3 pct)     (+16.4 pct)    (-83.9 pct)  (-57.7 pct) 
  Recurring        7.17           11.41           2.20         2.40    
               (-37.2 pct)     (+18.4 pct)    (-69.3 pct)  (-48.9 pct) 
  Net
  Net              5.48            9.05           2.70         1.70    
               (-39.4 pct)     (+17.1 pct)    (-50.7 pct)  (-49.1 pct) 
  EPS          117.33 yen      188.26 yen      57.80 yen    36.39 yen  
  Ann Div       50.00 yen       48.00 yen      52.00 yen               
  -Q2 Div       25.00 yen       24.00 yen      26.00 yen               
  -Q4 Div       25.00 yen       24.00 yen      26.00 yen               
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T